Abiopharma

🔍 Kelly Jason P (Executive)

Company: Inspire Medical Systems, Inc. (INSP)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Acquired 6,350 shares of Common Stock (Direct)
  Date: 2026-08-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 25,335.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on August 31, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
• REMARKS: Title - Chief Operations and Innovation Officer